RxNews Recap for Tuesday 11-24-09 Print E-mail
By Mary Davila   
Tuesday, 24 November 2009 20:57
Below is a list of the companies that made news in the healthcare sector on Tuesday, November 24, 2009.

Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.

Advanced Cell Technology, Inc. (OTCBB:ACTC)
, a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it will present at the LD Micro Conference on Thursday December 3, 2009 at 4:30 p.m. (PST) at the Luxe Hotel in Los Angeles.

Affymax, Inc. (Nasdaq:AFFY)
today announced the closing of its underwritten public offering of 4,726,027 shares of its common stock, which includes the full exercise of the underwriter’s overallotment option of 616,438 shares.

BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming Piper Jaffray 21st Annual Health Care Conference on Tuesday, December 1, 2009, at 3:30pm ET at The New York Palace Hotel in New York, NY.

BioScrip, Inc. (Nasdaq: BIOS) today announced that the company will present at the 21st Annual Piper Jaffray Health Care Conference to be held December 1-2, 2009 t the New York Palace in New York City.

CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH)
, a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").

deCODE genetics, Inc. (Nasdaq:DCGN)
today announced the approval of all of its "first day" motions by the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). deCODE last week filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the Bankruptcy Court.

Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the 13th Annual Biotech and Specialty Pharmaceuticals Conference, sponsored by the New York Society of Securities Analysts, at 2:05 on December 1, 2009.

Global Pharmaceuticals, the generic products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced their cooperation in awarding a modest grant to Myasthenia Gravis Alliance, also known as Myasthenia Gravis Foundation of Greater New York, Inc., a 501(3)(c) non profit membership corporation, incorporated in the State of New York.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that Philip Vaidyan, M.D., FACP, an IPC hospitalist, was named by ACP Hospitalist as one of the 2009 Top Ten Hospitalists in the nation. He was recognized in the November 2009 issue of the magazine.

ImmunoGen, Inc. (Nasdaq: IMGN)
, a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload (TAP) technology will be made at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition to be held in New Orleans, LA, on December 5-8, 2009.

Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) a growing developer and producer of prescriptions drugs and license national seller of pharmaceutical products in the People's Republic China, today reported it will exhibit at the 62nd PHARMCHINA as a member of the Beijing pharmaceutical delegation.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 21st Annual Piper Jaffray Health Care Conference in New York.

NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the appointment of John A. Orwin to its Board of Directors, effective November 19, 2009.

OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm's TrialMaster EDC solution for conducting a Phase II vaccine study.

Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company that specializes in In Vitro Diagnostic (IVD) cancer tests and cell-renewing skin care products, announced today unaudited results and the filing of its Form 10-Q with the Securities and Exchange Commission ("SEC") for fiscal third quarter FY2009.

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2009.

Synovis Life Technologies, Inc. (Nasdaq: SYNO)
, announced today that it has hired Patrick L. Horan to fill the key role of vice president of sales for the Surgical Group.

Santarus, Inc. (NASDAQ:SNTS),
a specialty biopharmaceutical company, today announced that Gerald T. Proehl, president and chief executive officer, will make a presentation at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, December 2, 2009, at 12:30 p.m. Eastern time (9:30 a.m. Pacific time) at The New York Palace Hotel in New York City.

ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the Piper Jaffray Healthcare Conference in New York City on Wednesday, December 2, 2009 at 8:30 a.m. Eastern Time.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus